Prosight Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$382K	Sell	159,692 -26,878	-14%	-$64.2K	0.09%	37
2025 Q1	$802K	Buy	186,570 +122,816	+193%	+$528K	0.26%	34
2024 Q4	$548K	Buy	+63,754	New	+$548K	0.15%	35
2021 Q3	–	Sell	-5,493	Closed	-$513K	–	51
2021 Q2	$513K	Buy	+5,493	New	+$513K	0.32%	40